J
Jacob A. Doll
Researcher at University of Washington
Publications - 60
Citations - 747
Jacob A. Doll is an academic researcher from University of Washington. The author has contributed to research in topics: Myocardial infarction & Medicine. The author has an hindex of 11, co-authored 48 publications receiving 498 citations. Previous affiliations of Jacob A. Doll include Veterans Health Administration & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
Participation in Cardiac Rehabilitation Programs Among Older Patients After Acute Myocardial Infarction
Jacob A. Doll,Anne S. Hellkamp,P. Michael Ho,Michael C. Kontos,Mary A. Whooley,Eric D. Peterson,Tracy Y. Wang +6 more
TL;DR: Using a national quality improvement registry, rates of enrollment in cardiac rehabilitation, as well as completeness of participation (number of sessions attended), among older adults and compared characteristics between patients who did and did not participate after referral are compared.
Journal ArticleDOI
A team‐based approach to patients in cardiogenic shock
Jacob A. Doll,Jacob A. Doll,E. Magnus Ohman,E. Magnus Ohman,Manesh R. Patel,Manesh R. Patel,Carmelo A. Milano,Joseph G. Rogers,David Wohns,Navin K. Kapur,Sunil V. Rao,Sunil V. Rao +11 more
TL;DR: A multidisciplinary cardiogenic shock team is recommended to guide the rapid and efficient use of these available treatments, making time‐dependent decision‐making more challenging.
Journal ArticleDOI
Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction.
Jacob A. Doll,Jacob A. Doll,Anne S. Hellkamp,Laine Thomas,P. Michael Ho,Michael C. Kontos,Mary A. Whooley,Mary A. Whooley,Thomas F. Boyden,Eric D. Peterson,Eric D. Peterson,Tracy Y. Wang,Tracy Y. Wang +12 more
TL;DR: Number of cardiac rehabilitation sessions attended was associated with improved medication adherence and lower downstream cardiovascular risk in a dose-response relationship, providing support for the continued use of cardiac Rehabilitation for older adults and encourages efforts to maximize attendance.
Journal ArticleDOI
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel
Jacob A. Doll,Megan L. Neely,Matthew T. Roe,Paul W. Armstrong,Harvey D. White,Dorairaj Prabhakaran,Kenneth J. Winters,Suman Duvvuru,Scott S. Sundseth,Joseph A. Jakubowski,Paul A. Gurbel,Deepak L. Bhatt,E. Magnus Ohman,Keith A.A. Fox,Keith A.A. Fox,Trilogy Acs Investigators +15 more
TL;DR: YP2C19 metabolizer status is not associated with the composite outcome of cardiovascular death, MI, or stroke in medically managed ACS patients treated with clopidogrel or prasugrel and these findings do not support routine CYP1C19 genetic testing in this population.
Journal ArticleDOI
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program.
Akash Kataruka,Charles Maynard,Kathleen E. Kearney,Ahmed N. Mahmoud,Sean Bell,Jacob A. Doll,James M. McCabe,Chistopher Bryson,Hitinder S. Gurm,Hani Jneid,Salim S. Virani,Eric J. Lehr,Michael E. Ring,Ravi S. Hira +13 more
TL;DR: Clinical acuity increased for patients treated with PCI rather than CABG, which resulted in an increase in adjusted observed/expected mortality ratio for patients undergoing PCI and a decrease for CABGs between 2014 and 2017.